Furthermore, dramatical reductions of liver function (AST, ALT), lipids profile (TG, TC) and attenuation of hepatic steatosis in hepatic HE assay with INU intervention support that dietary INU can effectively attenuate the progression of NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.